Doctors & patients are saying about 'A-Fib.com'...
"A-Fib.com is a great web site for patients, that is unequaled by anything else out there."
Dr. Douglas L. Packer, MD, FHRS, Mayo Clinic, Rochester, MN
"Jill and I put you and your work in our prayers every night. What you do to help people through this [A-Fib] process is really incredible."
Jill and Steve Douglas, East Troy, WI
“I really appreciate all the information on your website as it allows me to be a better informed patient and to know what questions to ask my EP.
Faye Spencer, Boise, ID, April 2017
“I think your site has helped a lot of patients.”Dr. Hugh G. Calkins, MD Johns Hopkins,
Baltimore, MD
FAQs A-Fib Drug Therapy: Infrequent A-Fib & Blood Thinners
“I have infrequent episodes of A-Fib. Do I have to be on a blood thinner for risk of a stroke?”
When blood is stagnant and not being pumped out of the left atrium, a clot can form. When the left atrium starts beating again, this clot can be pushed downstream into the left ventricle which then pumps this clot into the legs, lungs, brain or other organs causing an ischemic stroke.
But these clots aren’t formed instantly. It takes a while for stagnant blood to pool and clot. For example, if you have a ten minute attack of A-Fib, conventional wisdom says it’s unlikely a clot will develop.
The American College of Chest Physicians recommends that anticoagulation therapy be started after two days. The highest risk of an ischemic stroke often peaks 1 to 5 days after an A-Fib episode.
Data From Case-Crossover Study
Data from a 2021 case-crossover study of patients with atrial fibrillation and cardiac implantable electronic devices (CIEDs) is providing further insight into the associations between A-Fib episodes and risk of stroke.
Among more than 450,000 patients included in the study, results suggest patients experiencing an arrhythmic state for 5.5 hours were associated with a more than 3-fold increase in odds of a stroke, with a 5-fold increase for stroke observed within the next 1-5 days after experiencing A-Fib.
“Overall, these findings significantly underscore traditional thinking that A-Fib is likely a causal risk factor for ischemic stroke as opposed to just a risk marker,” said Daniel Singer, MD, professor of medicine at Harvard Medical School, professor in the Department of Epidemiology at the Harvard T.H. Chan School of Public Health.
Stroke Risk Decreases Rapidly After A-Fib Episode
According to Dr. Singer, “the results indicate that prolonged episodes of A-Fib increase stroke risk, but this risk decreases rapidly following the end of the episode.”
For infrequent episodes of A-Fib, these findings raise the possibility that a “pill-in-the-pocket” approach to anticoagulation may be an effective stroke prevention strategy.
The Most Recent Management Guidelines
The 2023 Guidelines for Diagnosis and Management of Atrial Fibrillation states:
Clots take time to form (e.g. “lasting ≥24 hours”). Under the new guideline, most patients whose A-Fib episodes last less than 5 minutes should not receive Oral Anticoagulant.
Before, it was thought that even a short A-Fib episode (less than 5 minutes) could cause a clot and stroke.
If your infrequent episodes of A-Fib are brief, discuss the current Guidelines with your doctor to determine your best choice regarding anticoagulation and your risk of stroke.
To learn more about the 2023 Guidelines, see Empowering Patients: Review of the “Guideline for Diagnosis & Management of Atrial Fibrillation”.
To learn more about Pill-in-the-Pocket anticoagulation, see FAQs A-Fib Drug Therapy: Pill in Pocket.
Return to FAQ Drug Therapies
Last updated: Sunday, September 27, 2026
